REGEN BIOPHARMA, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
REGEN BIOPHARMA, INC. (RGBP) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of -$4.79 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-10-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2019-10-24
- REGEN BIOPHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2019-06-30 was -$4.79K.
- REGEN BIOPHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$2.50K.
- REGEN BIOPHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2018-06-30 was $0.00.
- REGEN BIOPHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2018-03-31 was $0.00.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2019-06-30 | -$4.79K 10-Q · filed 2019-10-24 | -$7.29K derived: sum of 2 quarters · filed 2019-10-24 | -$7.29K 10-Q · filed 2019-10-24 |
| 2019-03-31 | -$2.50K 10-Q · filed 2019-08-29 | -$2.50K 10-Q · filed 2019-08-29 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-10-24 | $0.00 derived: sum of 2 quarters · filed 2019-10-24 | $0.00 10-Q · filed 2019-10-24 |
| 2018-03-31 | $0.00 10-Q · filed 2019-08-29 | $0.00 10-Q · filed 2019-08-29 |